Search
Processa Pharmaceuticals Inc
PCSAAdd to Watchlist
1.860USD
+0.020+1.09%
Close 11-13 16:00（ET）
5.21MMarket Cap
LossP/E TTM
Processa Pharmaceuticals Inc (PCSA) Stock Price Target & Forecast
Target Price
25.000USD+1119.51%
PCSA Analyst Recommendation Trends
In the current month, PCSA has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PCSA average Analyst price target in the last month is 25.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
PCSA Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, PCSA EPS is projected to reach -1.000 in FY2026Q3, following reported EPS of -1.187 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.50
-1.00
-1.00
-1.00
-0.75
Actual
-1.49
-1.29
-1.19
--
--
Surprise
+0.76%
-28.75%
-18.71%
--
--
FAQs
What is Processa Pharmaceuticals Inc's price target?
Analysts forecast that Processa Pharmaceuticals Inc's price target is USD 25.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 25.00.
How have Processa Pharmaceuticals IncPCSA's recent earnings per share performed?
The market expectation was USD -1.19, while Processa Pharmaceuticals IncPCSA's earnings per share (EPS) for the previous quarter was USD -1.29. EPS for the next quarter is expected at USD -1.00.